관련문헌 등
·Bradley's Neurology in Clinical Practice, Seventh edition.Chapter 96. Parkinson Disease and Other Movement Disorders.
·Harrison's Principles of Internal Medicine, 19e>449. Parkinson's Disease and Other Movement Disorders.
·T.A. Zesiewicz, R.J. Elble, E.D. Louis, et al. Evidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2011;77;1752-1755.
·T.A. Zesiewicz, R.J. Elble, E.D. Louis, et al. Practice Parameter: Therapies for essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005;64;2008-2020.
·Mario Zappia, Alberto Albanese, Elisa Bruno, et al. Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol (2013) 260:714？40.
·Theresa Ann Zesiewicz, Sheng-Han Kuo, et al. Essential Tremor. BMJ Clin Evid. Author manuscript; available in PMC 2016 April 22.
·Gunther Deuschl, Jan Raethjen, Helge Hellriegel, et al. Treatment of patients with essential tremor. Lancet Neurol 2011; 10: 148？61.
·Serrano-Duenas M. Use of primidone in low doses (250mg/day) versus high doses (750mg/day) in the management of essential tremor: Double-blind comparative study with one-year follow up. Parkinsonism Relat Disord. 2003 Oct;10(1):29-33.
·Gorman WP, Cooper R, Pocock P, Campbell MJ. A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry 1986; 49: 64？.68.
·Findley LJ, Cleeves L, Calzetti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry 1985, 48: 911？15.
·Findley LJ, Calzetti S. Double-blind controlled study of primidone in essential tremor: preliminary results. Br Med J (Clin Res Ed)1982, 285: 608.